LIRAGLUTIDE

Generic: LIRAGLUTIDE

Orbicular Pharmaceutical Technologies Private LimitedManufacturer
SUBCUTANEOUSRoute
LIRAGLUTIDEActive Substance
2026-01-14Original Approval

LIRAGLUTIDE is FDA application ANDA217590, sponsored by ORBICULAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DYSPNOEA
313 reports
2
ANXIETY
232 reports
3
CONDITION AGGRAVATED
231 reports
4
PRODUCT DOSE OMISSION ISSUE
210 reports
5
NO ADVERSE EVENT
209 reports
6
NAUSEA
201 reports
7
ASTHMA
195 reports
8
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
191 reports
9
WHEEZING
190 reports
10
HYPOTHYROIDISM
187 reports